Detailed price information for Mimedx Group Inc (MDXG-Q) from The Globe and Mail including charting and trades.
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
Detailed price information for Merit Medical Sys (MMSI-Q) from The Globe and Mail including charting and trades.
Orpyx® Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will ...
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer A key but often overlooked question in oncology clinical ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
The end of randomised control trials is on the cards, a healthcare data expert predicts. The end of randomised control trials is on the cards, a healthcare data expert predicts. Speaking at the Wired ...
Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean–DASH ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback